Clinical Trial Update: TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TCHP versus EC-THP as neoadjuvant therapy for HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EC-THP
• TCHP

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: HER2-Positive Breast Cancer | Phase 2 | Status: UNKNOWN